Skip to main content
. Author manuscript; available in PMC: 2018 Dec 3.
Published in final edited form as: J Acquir Immune Defic Syndr. 2007 Apr 1;44(4):470–477. doi: 10.1097/QAI.0b013e31802f1318

TABLE 2.

Description of Key Measures of Depression, Psychosocial Support, and Clinical Status for the Study Cohort (N = 996)

Depression and Social Support N % Clinical Status N %
Depression
 None 430 43.2
 At least once 566 56.8
Depression by follow-up time period Clinical WHO stage at enrollment
 Antepartum (n = 891) 380 42.7  WHO stage I 815 81.8
 Long-term follow-up (≥12 mo postpartum) 343 45.3  WHO stage II 171 17.2
 WHO stage III 10 1.0
“Persistence” of depression* CD4 count at enrollment (cells/µL)
 Not depressed at either time 224 34.3  <200 117 12.4
 Depressed at one time period 271 41.6  200–499 536 56.8
 Depressed at both time periods 157 24.1  ≥500 291 30.8
Social support Counseling/group attendance
 Low (<10th percentile score) 117 12.0  None 623 62.6
 Moderate (10–50th percentile) 382 39.2  At least once 373 37.4
 High (>50th percentile score) 476 48.8
*

Only 652 women with observations during pregnancy and more than 12 months postpartum were included.

n = 975 women with social support measures at enrollment; n = 21 had missing values.

n = 944 women with CD4 cell count measures at enrollment; n = 52 had missing values.